Health
Novel treatment avenue for resistant cancers: Removing SORLA protein from drug-resistant HER2-positive cancer cell lines – Medical Xpress
SORLA is a protein trafficking receptor that has been mainly studied in neurons, but it also plays a role in cancer cells. Professor Johanna Ivaska’s research group…
SORLA is a protein trafficking receptor that has been mainly studied in neurons, but it also plays a role in cancer cells. Professor Johanna Ivaska’s research group at Turku Bioscience observed that SORLA functionally contributes to the most reported therapy-resistant mechanism by which the cell-surface receptor HER3 counteracts HER2 targeting therapy in HER2-positive cancers. Removing SORLA from cancer cells sensitized anti-HER2 resistant breast cancer brain metastasis to targeted therapy.
HER2…
-
Noosa News13 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News14 hours agoMotorcyclist dies in crash with truck
-
Noosa News15 hours agoSomerville House investigating after teachers’ dossier on students leaked
-
General20 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging